FDA Approves Companion Diagnostic for Adjuvant Atezolizumab in Stage II to IIIA NSCLC – OncLive

The FDA has approved the VENTANA PD-L1 assay to assist in identifying which adult patients with stage II to IIIA non–small cell … News release.

By |2021-10-23T00:22:18+00:00October 23rd, 2021|Uncategorized|0 Comments

About the Author:

Related Posts

BioMarin Pharmaceutical (BMRN) Receives FDA Approval for Expanded Use of PALYNZIQ …
BioMarin Pharmaceutical (BMRN) Receives FDA Approval for Expanded Use of PALYNZIQ …
Dror Ortho-Design Receives 510(k) FDA Clearance for Next-Generation Smile Correction Solution
Dror Ortho-Design Receives 510(k) FDA Clearance for Next-Generation Smile Correction Solution
How Exelixis’ Earnings Beat and FDA Zanzalintinib Milestone Will Impact Exelixis (EXEL) Investors
How Exelixis’ Earnings Beat and FDA Zanzalintinib Milestone Will Impact Exelixis (EXEL) Investors
U.S. border officers searching more phones and devices at ports of entry – YouTube
U.S. border officers searching more phones and devices at ports of entry – YouTube
Critical swing state candidates reveal where they stand on DHS funding after suspected terror attacks
Critical swing state candidates reveal where they stand on DHS funding after suspected terror attacks